MEF2C is a transcription factor that has known functions in a variety of cell types, but it has not yet been ascribed a role in natural killer cells. Data now show that MEF2C promotes the functional responses of human and murine natural killer cells by controlling their metabolic programs.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Li, J. et al. Nat. Immunol. https://doi.org/10.1038/s41590-024-01811-2 (2024).
Assali, A., Harrington, A. J. & Cowan, C. W. Curr. Opin. Neurobiol. 59, 49–58 (2019).
Lin, Q., Schwarz, J., Bucana, C. & Olson, E. N. Science 276, 1404–1407 (1997).
Stehling-Sun, S., Dade, J., Nutt, S. L., DeKoter, R. P. & Camargo, F. D. Nat. Immunol. 10, 289–296 (2009).
Zhao, X. et al. Cell. Mol. Immunol. 19, 540–553 (2022).
Seok, J. et al. Proc. Natl Acad. Sci. USA 110, 3507–3512 (2013).
Wong, P. et al. J. Clin. Invest. 133, e162530 (2023).
Sohn, H. & Cooper, M. A. Immunometabolism 5, e00020 (2023).
Kobayashi, T. et al. Blood 136, 3004–3017 (2020).
Michelet, X. et al. Nat. Immunol. 19, 1330–1340 (2018).
Geiger, T. L. & Sun, J. C. Curr. Opin. Immunol. 39, 82–89 (2016).
Berrien-Elliott, M. M., Jacobs, M. T. & Fehniger, T. A. Blood 141, 856–868 (2023).
Acknowledgements
T.A.F. is supported by the National Institutes of Health (grants P50CA171963 and P30CA91842), Siteman Cancer Center Investment Program, Children’s Discovery Institute, Leukemia and Lymphoma Society, Lymphoma Research Foundation, Institute for Follicular Lymphoma Innovation, Rising Tide Foundation for Cancer Research, and Melanoma Research Alliance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.A.F. discloses equity, consulting, licensed patents, and research funding from Wugen; equity in Orca Bio and Indapta; and membership of the scientific advisory board and/or research agreements with Affimed, Smart Immune, HCW Biologics, and AI Proteins. P.W. declares no competing interests.
Rights and permissions
About this article
Cite this article
Wong, P., Fehniger, T.A. Fat matters for natural killer cell activity. Nat Immunol (2024). https://doi.org/10.1038/s41590-024-01825-w
Published:
DOI: https://doi.org/10.1038/s41590-024-01825-w